Presenting at the Aegis Conference today. Read the recent Yahoo news.
Expected to announce a deal soon with Becton Dickinson to market its diagnostic test to detect early stage Alzheimer's. Potential $500,000,000 annual market.
The company recently announced an "orphan indication" for its patented MANF drug to treat Retinitis Pigmentosa.
Dr. Joseph Rubinfeld, one of the co-founders of Amgen, is on the company's advisory board.
Follow the company on Twitter: @AmarantusBio .... 8,535 followers